Latest Security News

Mandrake Resources has signed a non-binding Letter of Intent to supply lithium chloride to US refinery Stardust Power, marking a strategic step in the US push for domestic critical minerals.

Platina Resources has identified five promising target zones at its Mt McKenna Gold Project in Western Australia, setting the stage for imminent drilling after securing key approvals and completing detailed surveys.

Westpac Banking Corporation reported a modest decline in full-year net profit, while advancing key transformation initiatives and raising dividends slightly.

Skin Elements Limited reports successful completion of key product evaluations and secures $2.5 million placement to fuel growth and commercialisation in 2026.

FBR Limited unveiled its new DST-enabled Mantis welding robot targeting heavy fabrication sectors while completing key milestones on its Hadrian bricklaying technology and securing a $22 million financing package.

Avenira Limited reports significant progress at its Wonarah Phosphate Project, alongside key board and management changes, while maintaining a solid cash position at the end of Q3 2025.

ClearVue Technologies has secured a $4.6 million capital raise and signed major partnerships, setting the stage for commercialisation in 2026 with a robust $60 million project pipeline.

Genmin Limited has made significant progress on its Baniaka iron ore project in Gabon, with PowerChina submitting competitive engineering and construction proposals and the company securing A$15 million in director-related loans during the quarter.

Metal Bank Limited reported a net cash increase of A$201,000 for Q3 2025, supported by a $2.3 million entitlement issue to fund recent gold project acquisitions.

Horseshoe Metals has secured mining approval for Direct Shipping Ore operations at its Horseshoe Lights project, complemented by promising drilling assays and strategic funding to accelerate development.

Noble Helium advances its North Rukwa helium project with a confirmed five-hole drilling campaign and a significant resource upgrade, backed by leadership changes and shareholder funding.

Argent BioPharma has secured a transformative acquisition of AusCann’s core assets, bolstering its drug delivery technology and manufacturing capabilities ahead of a planned U.S. listing. The company also reported key clinical milestones and refinancing moves in its September 2025 quarterly update.